Evidence map›Paper›PMID 18545705›Full record

ArticlePloS one2008

Allogeneic lymphocytes persist and traffic in feral MHC-matched mauritian cynomolgus macaques.

Justin M Greene, Benjamin J Burwitz, Alex J Blasky, Teresa L Mattila, Jung Joo Hong, Eva G Rakasz, Roger W Wiseman, Kim J Hasenkrug, Pamela J Skinner, Shelby L O'Connor and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 23 citations in OpenAlex.

  1. EfficientFrontiers in immunology · 2023
    Article
  2. Article
  3. Review
  4. Nonhuman primate models of human viral infections.Nature reviews. Immunology · 2018
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Justin M GreeneDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Benjamin J Burwitz
Alex J Blasky
Teresa L Mattila
Jung Joo Hong
Eva G Rakasz
Roger W Wiseman
Kim J Hasenkrug
Pamela J Skinner
Shelby L O'Connor
David H O'Connor
University of Wisconsin–Madison · USUniversity of Minnesota · USNational Institute of Allergy and Infectious Diseases · US

Funding

WNPRC Supplemental Request for Nonhuman Primate Enclosures to Equip HIV/AIDS-Related Research FacilitiesP51OD011106 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI Dorota A. Grejner-Brzezinska · 2012 to 2026
$150.7M
ZOLEDRONATE PREVENTS BONE LOSS IN OVARIECTOMIZED RHESUS MONKEYSP51RR000167 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 1985 to 2011
$106.7M
EXTRAMURAL RES FACIL CONST: REPRODUCTIVE, GROWTH &DVMT, MENOPAUSEC06RR020141 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI CADWALLADER, MARTIN · 2004 to 2004
$3.6M
Immunology/Pathology Of Murine Leukemia Virus InfectionsZ01AI000753 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI HASENKRUG, KIM · 1996 to 2008
$3.5M
Immunogenetics of Primates Used for Bioterror ResearchR24RR021745 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI O'CONNOR, DAVID H. · 2005 to 2011
$3.3M
Immunology and Pathology of Chronic Murine Leukemia Virus InfectionsZIAAI001100 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HASENKRUG, KIM · 2009 to 2015
$3.1M
EXTRAMURAL REGIONAL FACILITIES CONSTRUCTIONC06RR015459 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI CADWALLADER, MARTIN · 2000 to 2000
$1.9M
SIV-Specific CD8+ T-Cell in Mauritian Cynomolgus MacaquesR21AI068488 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI O'CONNOR, DAVID H. · 2006 to 2007
$507k
NCRR NIH HHS C06 RR015459NCRR NIH HHS C06 RR020141NCRR NIH HHS P51 RR000167NCRR NIH HHS R24 RR021745NCRR NIH HHS RR020141-01NCRR NIH HHS RR021745-01A1NCRR NIH HHS RR15459-01NIAID NIH HHS 1R21AI068488-01A2NIAID NIH HHS R21 AI068488NIH HHS P51 OD011106
6 · The paper itself

Abstract

backgroundThus far, live attenuated SIV has been the most successful method for vaccinating macaques against pathogenic SIV challenge; however, it is not clear what mechanisms are responsible for this protection. Adoptive transfer studies in mice have been integral to understanding live attenuated vaccine protection in models like Friend virus. Previous adoptive transfers in primates have failed as transferred cells are typically cleared within hours after transfer. METHODOLOGY/ PRINCIPAL

findingsHere we describe adoptive transfer studies in Mauritian origin cynomolgus macaques (MCM), a non-human primate model with limited MHC diversity. Cells transferred between unrelated MHC-matched macaques persist for at least fourteen days but are rejected within 36 hours in MHC-mismatched macaques. Cells trafficked from the blood to peripheral lymphoid tissues within 12 hours of transfer. CONCLUSIONS/SIGNIFICANCE: MHC-matched MCM provide the first viable primate model for adoptive transfer studies. Because macaques infected with SIV are the best model for HIV/AIDS pathogenesis, we can now directly study the correlates of protective immune responses to AIDS viruses. For example, plasma viral loads following pathogenic SIV challenge are reduced by several orders of magnitude in macaques previously immunized with attenuated SIV. Adoptive transfer of lymphocyte subpopulations from vaccinated donors into SIV-naïve animals may define the immune mechanisms responsible for protection and guide future vaccine development.

Indexed as

Adoptive TransferAnimals, WildMajor Histocompatibility ComplexAnimalsBase SequenceCD8-Positive T-LymphocytesDNA PrimersHaplotypesMacaca fascicularisMicrosatellite RepeatsSimian Immunodeficiency VirusDNA Primers

Identifiers

PMID18545705
PMCPMC2408966
OpenAlexW2021934926

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.